Peer-reviewedCC BY-NC-NDTranslational andrology and urology
SESN2 promotes ferroptosis in bladder cancer by negatively regulating the NRF2/FSP1 signaling axis
- 1Department of Urology , Xi’an Chang’an Hospital , Xi’an , ;
- 2Department of Urology , The Second Affiliated Hospital of Xi’an Medical University , Xi’an , ;
- 3Department of Urology , Xi’an Gemflower Changqing Hospital (Changqing Oilfield Workers’ Hospital) , Xi’an ,
Related
- Targeting REV7 confers cervical cancer cell radiosensitivity and ferroptosis by negatively regulating SFXN1
- CDCA5 promotes hepatocellular carcinoma progression by suppressing ferroptosis through PP2Ac/p53/STEAP3 signaling
- Benzene metabolite catechol promotes microglia-mediated neuroinflammation in Alzheimer’s disease via regulating NF-κB signaling
- Filamin A Promotes Malignant Progression and Poor Prognosis in Glioma by Regulating EMT-Related Signaling Pathways.
- SLCO1B3 is associated with poor survival and promotes bladder cancer progression through Wnt/β-catenin signaling.
BibTeX
@article{hu2026sesn2,
title = {{SESN2 promotes ferroptosis in bladder cancer by negatively regulating the NRF2/FSP1 signaling axis}},
author = {Jianfeng Hu and Yangmin Wang and Yonghui Du and Xi’an Li and Zhiguo Zhang and Xuehai Liang and Junfeng Peng},
journal = {Translational andrology and urology},
year = {2026},
month = aug,
url = {https://europepmc.org/article/PMC/PMC13657751},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - SESN2 promotes ferroptosis in bladder cancer by negatively regulating the NRF2/FSP1 signaling axis
AU - Jianfeng Hu
AU - Yangmin Wang
AU - Yonghui Du
AU - Xi’an Li
AU - Zhiguo Zhang
AU - Xuehai Liang
AU - Junfeng Peng
PY - 2026
DA - 2026/08/28
JO - Translational andrology and urology
UR - https://europepmc.org/article/PMC/PMC13657751
SN - 2223-4691
ER -